Navigating the Clinical Research Process for Glioma
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT05958472
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of glioma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future glioma patients.
Key Dates
- Start date
- Aug 31, 2024
- Status verified
- Jul 2023
- Primary completion
- Aug 31, 2025
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Rate of patients who decide to enroll in a glioma clinical research. [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill4159004227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 |
Find similar trials in San Francisco, CA
Related Studies
- Hyperpolarized Imaging in Diagnosing Participants With GliomaPHASE1 · Recruiting · Susan Chang · San Francisco, California
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)PHASE3 · Recruiting · Nuvation Bio Inc. · Birmingham, Alabama
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPHASE1 · Recruiting · Pfizer · Birmingham, Alabama
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsRecruiting · Jona Hattangadi-Gluth · San Diego, California